Henry Ford Health System Will Study the Effectiveness of Anti-Malarial Drug on COVID-19
Henry Ford Health Systems will be the first U.S. hospital to conduct large scale tests on antimalarial drug Hydroxychloroquine, and its effectiveness in preventing the spread of COVID-19. The “Will Hydroxychloroquine Impede or Prevent COVID-19,” or WHIP COVID-19 Test will look at the usefulness of